Plain-English translation of NCT04692818 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new type of ultrasound imaging called 3D Multimodal Ultrasound Imaging to see if it can help doctors better diagnose breast tumors. If you have a breast lesion that needs a biopsy as part of your regular medical care, you would have this new imaging method performed in addition to your standard biopsy. The goal is to learn whether this imaging technique can improve how accurately doctors identify breast cancer.
Current ultrasound methods work reasonably well, but doctors want to know if this new 3D imaging approach could be even better at detecting and characterizing breast tumors. This research aims to fill that gap and potentially improve diagnosis for women with breast concerns.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you would receive the new 3D ultrasound imaging as an addition to your already-scheduled breast biopsy. The imaging would be performed before or alongside your standard biopsy procedure. The study is designed to gather information from approximately 125 women to evaluate how well this new imaging method works.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States
Sponsor
Mayo Clinic
Collaborators
United States Department of Defense
Enrollment target
~125 participants
Started
November 2021
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bobbie Ott
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.